FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 65 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,272,856 | -44.3% | 1,026,654 | +1.3% | 0.00% | – |
| Q1 2024 | $11,271,521 | -11.9% | 1,013,626 | -11.1% | 0.00% | – |
| Q4 2023 | $12,791,507 | +1983.0% | 1,140,063 | +1294.3% | 0.00% | – |
| Q3 2023 | $614,078 | -12.9% | 81,768 | +2.4% | 0.00% | – |
| Q2 2023 | $705,279 | +1.9% | 79,873 | -28.3% | 0.00% | – |
| Q1 2021 | $692,000 | -4.8% | 111,372 | +14.2% | 0.00% | – |
| Q4 2020 | $727,000 | +40.9% | 97,508 | +14.5% | 0.00% | – |
| Q3 2020 | $516,000 | -31.6% | 85,170 | -5.6% | 0.00% | – |
| Q2 2020 | $754,000 | +244.3% | 90,264 | +100.3% | 0.00% | – |
| Q1 2019 | $219,000 | -17.7% | 45,067 | +8.3% | 0.00% | – |
| Q4 2018 | $266,000 | -25.5% | 41,609 | -4.3% | 0.00% | – |
| Q3 2018 | $357,000 | -15.8% | 43,488 | +7.1% | 0.00% | – |
| Q2 2018 | $424,000 | – | 40,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $21,256,962 | 14.19% |
| Solas Capital Management, LLC | 1,439,028 | $12,706,617 | 8.46% |
| DG Capital Management, LLC | 1,074,654 | $9,489,195 | 4.23% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $4,122,453 | 2.31% |
| AIGH Capital Management LLC | 349,457 | $3,085,705 | 1.26% |
| APIS CAPITAL ADVISORS, LLC | 90,000 | $794,700 | 0.80% |
| Southpoint Capital Advisors LP | 4,077,214 | $36,001,800 | 0.78% |
| Worth Venture Partners, LLC | 93,252 | $823,415 | 0.45% |
| Lion Point Capital, LP | 110,000 | $971,300 | 0.44% |
| GENDELL JEFFREY L | 283,413 | $2,502,537 | 0.19% |